Stocks Health care CRLBF
OTC · Health careCresco Labs Inc. (CRLBF)
Cresco Labs Inc. reported revenue of $655.8M in fiscal 2025, down 9.5% from a year earlier. It posted a net loss of $135.4M. Operating cash flow minus capital spending left $37.8M of free cash flow in fiscal 2025. At December 31, 2025 it held $57.9M in cash against $420.4M of debt. Its latest periodic report to the SEC is the annual report (Canadian issuer) (40-F) filed on March 6, 2026.
Watch CRLBF in 60 secondsWhat Cresco Labs Inc. does
Cresco Labs Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CRLBF.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $655.8M | -$135.4M | -$0.38 | $37.8M |
| 2024 | $724.3M | -$74.4M | -$0.22 | $113M |
| 2023 | $770.9M | -$175.5M | -$0.54 | $3.2M |
| 2022 | $842.7M | -$212M | -$0.71 | -$64.3M |
| 2021 | $821.7M | -$319.6M | -$1.22 | -$79.4M |
| 2020 | $476.3M | -$102.2M | -$0.39 | -$95M |
Full financial statements: income, balance sheet and cash flow
Where CRLBF ranks in Health care
Latest SEC filings
What Cresco Labs Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 6, 2026
- May 8, 2026
- March 6, 2026Annual report (Canadian issuer) 40-F · period to December 31, 2025Revenue fell 9.5% to $655.8M versus the prior year; diluted EPS -$0.38 versus -$0.22.
- February 2, 2026
- November 7, 2025
- October 6, 2025Form F-X filing F-X
- October 6, 2025Form F-10 filing F-10
- September 22, 2025
- September 18, 2025Form SC TO-I/A filing SC TO-I/A
- September 17, 2025
Questions about CRLBF
What does Cresco Labs Inc. do?
Cresco Labs Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CRLBF.
Is Cresco Labs Inc. profitable?
No. In fiscal 2025 it reported a net loss of $135.4M on revenue of $655.8M.
How much revenue does Cresco Labs Inc. make?
In fiscal 2025 Cresco Labs Inc. reported revenue of $655.8M. That is 9.5% less than a year earlier.
When did Cresco Labs Inc. last report?
Its most recent periodic report is the annual report (Canadian issuer) (40-F) filed on March 6, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from August 6, 2026.
Similar companies
Compare CRLBF with
Compare CRLBF with any company
Follow CRLBF
Get an email when Cresco Labs Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CRLBF: get an email when it filesWhere the numbers come from
Financial figures are the values Cresco Labs Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.